Heavy-chain disease

Dietlind L. Wahner-Roedler, Robert A. Kyle

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The heavy-chain diseases (HCDs) are monoclonal lymphoplasma cell proliferative disorders involving B cells and are characterized by the synthesis of truncated heavy chains without associated light chains. The complex abnormalities of HCD proteins and the usual lack of normal light chains are due to several distinct gene alterations, including somatic mutations, deletions, and insertions. HCDs have been described for the three main immunoglobulin classes. The most frequent is α-HCD; μ-HCD is rare and the incidence of γ-HCD is intermediate. In contrast to γ-HCD and α-HCD, which usually have no detectable monoclonal light chains, the light chains that do not assemble with the secreted deleted heavy chains are produced in about two-thirds of cases of μ-HCD. The monoclonal proteins are always present in the serum and are often in the urine of patients with γ-HCD, but monoclonal heavy chains are infrequent in the urine in μ-HCD and occur in small amounts in α-HCD.

Original languageEnglish (US)
Title of host publicationNeoplastic Diseases of the Blood
PublisherSpringer New York
Pages701-728
Number of pages28
ISBN (Print)9781461437642, 1461437636, 9781461437635
DOIs
StatePublished - Nov 1 2013

Fingerprint

Heavy Chain Disease
Light
INDEL Mutation
Urine
Immunoglobulin Isotypes

Keywords

  • α-Heavy-chain disease
  • γ-Heavy-chain disease
  • μ-Heavy-chain disease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Wahner-Roedler, D. L., & Kyle, R. A. (2013). Heavy-chain disease. In Neoplastic Diseases of the Blood (pp. 701-728). Springer New York. https://doi.org/10.1007/978-1-4614-3764-2_36

Heavy-chain disease. / Wahner-Roedler, Dietlind L.; Kyle, Robert A.

Neoplastic Diseases of the Blood. Springer New York, 2013. p. 701-728.

Research output: Chapter in Book/Report/Conference proceedingChapter

Wahner-Roedler, DL & Kyle, RA 2013, Heavy-chain disease. in Neoplastic Diseases of the Blood. Springer New York, pp. 701-728. https://doi.org/10.1007/978-1-4614-3764-2_36
Wahner-Roedler DL, Kyle RA. Heavy-chain disease. In Neoplastic Diseases of the Blood. Springer New York. 2013. p. 701-728 https://doi.org/10.1007/978-1-4614-3764-2_36
Wahner-Roedler, Dietlind L. ; Kyle, Robert A. / Heavy-chain disease. Neoplastic Diseases of the Blood. Springer New York, 2013. pp. 701-728
@inbook{95750370299b4fa582a36ed0b5aed6f1,
title = "Heavy-chain disease",
abstract = "The heavy-chain diseases (HCDs) are monoclonal lymphoplasma cell proliferative disorders involving B cells and are characterized by the synthesis of truncated heavy chains without associated light chains. The complex abnormalities of HCD proteins and the usual lack of normal light chains are due to several distinct gene alterations, including somatic mutations, deletions, and insertions. HCDs have been described for the three main immunoglobulin classes. The most frequent is α-HCD; μ-HCD is rare and the incidence of γ-HCD is intermediate. In contrast to γ-HCD and α-HCD, which usually have no detectable monoclonal light chains, the light chains that do not assemble with the secreted deleted heavy chains are produced in about two-thirds of cases of μ-HCD. The monoclonal proteins are always present in the serum and are often in the urine of patients with γ-HCD, but monoclonal heavy chains are infrequent in the urine in μ-HCD and occur in small amounts in α-HCD.",
keywords = "α-Heavy-chain disease, γ-Heavy-chain disease, μ-Heavy-chain disease",
author = "Wahner-Roedler, {Dietlind L.} and Kyle, {Robert A.}",
year = "2013",
month = "11",
day = "1",
doi = "10.1007/978-1-4614-3764-2_36",
language = "English (US)",
isbn = "9781461437642",
pages = "701--728",
booktitle = "Neoplastic Diseases of the Blood",
publisher = "Springer New York",

}

TY - CHAP

T1 - Heavy-chain disease

AU - Wahner-Roedler, Dietlind L.

AU - Kyle, Robert A.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - The heavy-chain diseases (HCDs) are monoclonal lymphoplasma cell proliferative disorders involving B cells and are characterized by the synthesis of truncated heavy chains without associated light chains. The complex abnormalities of HCD proteins and the usual lack of normal light chains are due to several distinct gene alterations, including somatic mutations, deletions, and insertions. HCDs have been described for the three main immunoglobulin classes. The most frequent is α-HCD; μ-HCD is rare and the incidence of γ-HCD is intermediate. In contrast to γ-HCD and α-HCD, which usually have no detectable monoclonal light chains, the light chains that do not assemble with the secreted deleted heavy chains are produced in about two-thirds of cases of μ-HCD. The monoclonal proteins are always present in the serum and are often in the urine of patients with γ-HCD, but monoclonal heavy chains are infrequent in the urine in μ-HCD and occur in small amounts in α-HCD.

AB - The heavy-chain diseases (HCDs) are monoclonal lymphoplasma cell proliferative disorders involving B cells and are characterized by the synthesis of truncated heavy chains without associated light chains. The complex abnormalities of HCD proteins and the usual lack of normal light chains are due to several distinct gene alterations, including somatic mutations, deletions, and insertions. HCDs have been described for the three main immunoglobulin classes. The most frequent is α-HCD; μ-HCD is rare and the incidence of γ-HCD is intermediate. In contrast to γ-HCD and α-HCD, which usually have no detectable monoclonal light chains, the light chains that do not assemble with the secreted deleted heavy chains are produced in about two-thirds of cases of μ-HCD. The monoclonal proteins are always present in the serum and are often in the urine of patients with γ-HCD, but monoclonal heavy chains are infrequent in the urine in μ-HCD and occur in small amounts in α-HCD.

KW - α-Heavy-chain disease

KW - γ-Heavy-chain disease

KW - μ-Heavy-chain disease

UR - http://www.scopus.com/inward/record.url?scp=84929529858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929529858&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-3764-2_36

DO - 10.1007/978-1-4614-3764-2_36

M3 - Chapter

AN - SCOPUS:84929529858

SN - 9781461437642

SN - 1461437636

SN - 9781461437635

SP - 701

EP - 728

BT - Neoplastic Diseases of the Blood

PB - Springer New York

ER -